Search
Close this search box.

Current Edition

Current FeaturesVolume 4 Issue 1

Accelerating Sustainability in Pharma: A Q&A with Silvia Forroova, Director, Partnerships and Sustainability, and Founder of the Sustainability Collective at Informa Markets

The pharmaceutical industry is increasingly looking to meet the opportunities and needs of a broad agenda on sustainability, from the more efficient use of materials ...
Continue Reading →
Current FeaturesVolume 4 Issue 1

Living and Breathing: The Inhalation Industry’s Green Transition

Sustainability is multi-faceted. Beyond direct environmental impacts such as carbon emissions from manufacturing, a company’s sustainable practices should also account for indirect impacts across the ...
Continue Reading →
Current FeaturesVolume 4 Issue 1

Achieving Sustainability in Pharma Manufacturing

The environmental impact of the pharmaceutical industry is hard to quantify, but it has been suggested Pharma may be responsible for 300 million tons of ...
Continue Reading →
Current FeaturesVolume 4 Issue 1

Staying Ahead of Green Propellant Regulations in pMDIs Navigating the transition to green propellants, while maintaining performance and usability

The next few years will see substantial changes for pressurised metered-dose inhalers (pMDIs). As a result of emerging regulations such as the European Union’s F-Gas ...
Continue Reading →
Current FeaturesVolume 4 Issue 1

The Next Frontier for Inhaled Therapies: Low Global Warming Propellants and the Future of pMDI Development

The pharmaceutical inhalation industry stands at a pivotal crossroads. After decades of relative stability following the phase-out of CFCs in the 1990s, a second major ...
Continue Reading →